Integrative medicine: Complementary therapies and supplements

Nature Reviews Urology

Volumn 6, Issue 4, 2009, Pages 228-233

  Cassileth, Barrie R ^a   Gubili, Jyothirmai ^a   Simon Yeung, K ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; DIETHYLSTILBESTROL; HERBACEOUS AGENT; LYCOPENE; PYGEUM AFRICANUM EXTRACT; SABAL EXTRACT; SELENIUM; SOYBEAN PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUPUNCTURE; ALTERNATIVE MEDICINE; ANTIOXIDANT ACTIVITY; ANXIETY; ASTHMA; BACTERIURIA; BREAST CANCER; CHINESE MEDICINE; CHRONIC PAIN; CLINICAL TRIAL; CRANBERRY JUICE; CYSTOCELE; DIABETES MELLITUS; DRUG DEPENDENCE; EPIDIDYMITIS; FATIGUE; FEEDBACK SYSTEM; FITNESS; HEADACHE; HEART DISEASE; HORMONAL THERAPY; HOT FLUSH; HUMAN; HYPERTENSION; INTEGRATIVE MEDICINE; INTERSTITIAL CYSTITIS; MALIGNANT NEOPLASTIC DISEASE; MEDITATION; MIGRAINE; MUSIC THERAPY; NOTE; ORCHITIS; PELVIC ORGAN PROLAPSE; PELVIS PAIN SYNDROME; PHYSICAL ACTIVITY; PHYTOESTROGENIC ACTIVITY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; QUALITY OF LIFE; RECTOCELE; SOYBEAN; TERMINAL CARE; TRADITIONAL MEDICINE; URINARY FREQUENCY; URINARY TRACT INFECTION; URINARY URGENCY; URINE INCONTINENCE; UTERUS PROLAPSE; VULVODYNIA; YOGA; DIET SUPPLEMENTATION; METHODOLOGY; PATHOPHYSIOLOGY; REVIEW; URINARY TRACT CANCER;

COMPLEMENTARY THERAPIES; DIETARY SUPPLEMENTS; HUMANS; INTEGRATIVE MEDICINE; UROLOGIC NEOPLASMS;

EID: 76449116561     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2009.41     Document Type: Note

References (78)

1. Lippert, M. c. et al. Alternative medicine use in patients with localized prostate carcinoma treated with curative intent. Cancer 86, 2642-2648 (1999).
2. Dreikorn, K. complementary and alternative medicine in urology. BJU Int. 96, 1177-1184 (2005).
3. rackley, J. D. et al. complementary and alternative medicine for advanced prostate cancer. Urol. Clin. North Am. 33, 237-246 (2006).
4. society of integrative Oncology. www.integrativeonc.org (2009).
5. Wilkinson, s. et al. Attitudes and use of complementary medicine in men with prostate cancer. J. Urol. 168, 2505-2509 (2002).
6. Hall, J. D. et al. Motivations and influences on the use of complementary medicine in patients with localized prostate cancer treated with curative intent: results of a pilot study. BJU Int. 91, 603-607 (2003).
7. Listing, M. et al. Massage therapy reduces physical discomfort and improves mood disturbances in women with breast cancer. Psychooncology doi:10.1002/pon.1508 (2009).
8. cassileth, B. r. & vickers, A. J. Massage therapy for symptom control: outcome study at a major cancer center. J. Pain Symptom Manage. 28, 244-249 (2004).
9. pomeranz, B. & Warma, N. electroacupuncture suppression of a nociceptive reflex is potentiated by two repeated electroacupuncture treatments: the first opioid effect potentiates a second non-opioid effect. Brain Res. 452, 232-236 (1988).
10. Yoo, s. s. et al. Modulation of cerebellar activities by acupuncture stimulation: evidence from fMri study. Neuroimage 22, 932-940 (2004).
11. Honjo, H. et al. effects of acupuncture for chronic pelvic pain syndrome with intrapelvic venous congestion: preliminary results. Int. J. Urol. 11, 607-612 (2004).
12. ee, c. c. et al. Acupuncture for pelvic and back pain in pregnancy: a systematic review. Am. J. Obstet. Gynecol. 198, 254-259 (2008).
13. Baum, N. H. & torti, D. c. Managing hot flashes in men being treated for prostate cancer. Geriatrics 62, 18-21 (2007).
14. Guise, t. A. et al. estrogenic side effects of androgen deprivation therapy. Rev. Urol. 9, 163-180 (2007).
15. Filshie, J. et al. Acupuncture and self acupuncture for long-term treatment of vasomotor symptoms in cancer patients- audit and treatment algorithm. Acupunct. Med. 23, 171-180 (2005).
16. Hammar, M. et al. Acupuncture treatment of vasomotor symptoms in men with prostatic carcinoma: a pilot study. J. Urol. 161, 853-856 (1999).
17. Kingston, J. et al. A pilot randomized control trial investigating the effect of mindfulness practice on pain tolerance, psychological wellbeing, and physiological activity. J. Psychosom. Res. 62, 297-300 (2007).
18. Morone, N. e. et al. Mindfulness meditation for the treatment of chronic low back pain in older adults: a randomized controlled pilot study. Pain 134, 310-319 (2008).
19. paul-Labrador, M. et al. effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease. Arch. Intern. Med. 166, 1218-1224 (2006).
20. curiati, J. A. et al. Meditation reduces sympathetic activation and improves the quality of life in elderly patients with optimally treated heart failure: a prospective randomized study. J. Altern. Complement. Med. 11, 465-472 (2005).
21. Koszycki, D. et al. randomized trial of a meditation-based stress reduction program and cognitive behavior therapy in generalized social anxiety disorder. Behav. Res. Ther. 45, 2518-2526 (2007).
22. Lee, s. H. et al. effectiveness of a meditationbased stress management program as an adjunct to pharmacotherapy in patients with anxiety disorder. J. Psychosom. Res. 62, 189-195 (2007).
23. Watanabe, e. et al. effects among healthy subjects of the duration of regularly practicing a guided imagery program. BMC Complement. Altern. Med. 5, 21 (2005).
24. Mannix, L. K. et al. effect of guided imagery on quality of life for patients with chronic tensiontype headache. Headache 39, 326-334 (1999).
25. Holmes, e. A. et al. positive interpretation training: effects of mental imagery versus verbal training on positive mood. Behav. Ther. 37, 237-247 (2006).
26. carlson, L. e. et al. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHeAs) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinol. 29, 448-474 (2004).
27. carlson, L. e. et al. One year pre-post intervention follow-up of psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction (MBsr) in breast and prostate cancer outpatients. Brain Behav. Immun. 21, 1038-1049 (2007).
28. Hill, J. r. et al. patient perceived outcomes of treatments used for interstitial cystitis. Urology 71, 62-66 (2008).
29. Forrest, J. B. et al. chronic prostatitis/chronic pelvic pain syndrome and male interstitial cystitis: enigmas and opportunities. Urology 69, 60-63 (2007).
30. carrico, D. J. et al. Guided imagery for women with interstitial cystitis: results of a prospective, randomized controlled pilot study. J. Altern. Complement. Med. 14, 53-60 (2008).
31. ripoll, e. & Mahowald, D. Hatha Yoga therapy management of urologic disorders. World J. Urol. 20, 306-309 (2002).
32. smith, M. et al. Music as a therapeutic intervention for anxiety in patients receiving radiation therapy. Oncol. Nurs. Forum 28, 855-862 (2001).
33. Yung, p. M. et al. A controlled trial of music and pre-operative anxiety in chinese men undergoing transurethral resection of the prostate. J. Adv. Nurs. 39, 352-359 (2002).
34. ciancarelli, i. et al. relationship between biofeedback and oxidative stress in patients with chronic migraine. Cephalalgia 27, 1136-1141 (2007).
35. tsai, p. s. et al. Blood pressure biofeedback exerts intermediate-term effects on blood pressure and pressure reactivity in individuals with mild hypertension: a randomized controlled study. J. Altern. Complement. Med. 13, 547-554 (2007).
36. tsai, p. s. et al. effects of electromyography biofeedback-assisted relaxation on pain in patients with advanced cancer in a palliative care unit. Cancer Nurs. 30, 347-353 (2007).
37. Burgio, K. L. et al. preoperative biofeedback assisted behavioral training to decrease postprostatectomy incontinence: a randomized, controlled trial. J. Urol. 175, 196-201 (2006).
38. Kibar, Y. et al. effect of biofeedback treatment on spinning top urethra in children with voiding dysfunction. Urology 70, 781-784 (2007).
39. Demark-Wahnefried, W. et al. Main outcomes of the FresH stArt trial: a sequentially tailored, diet and exercise mailed print intervention among breast and prostate cancer survivors. J. Clin. Oncol. 25, 2709-2718 (2007).
40. truong, p. t. et al. prospective evaluation of the prevalence and severity of fatigue in patients with prostate cancer undergoing radical external beam radiotherapy and neoadjuvant hormone therapy. Can. J. Urol. 13, 3139-3146 (2006).
41. Windsor, p. M. et al. A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma. Cancer 101, 550-557 (2004).
42. Giubilei, G. et al. physical activity of men with chronic prostatitis/chronic pelvic pain syndrome not satisfied with conventional treatments-could it represent a valid option? the physical activity and male pelvic pain trial: a double-blind, randomized study. J. Urol. 177, 159-165 (2007).
43. Litwin, M. s. et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 273, 129-135 (1995).
44. Madalinska, J. B. et al. Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer. J. Clin. Oncol. 19, 1619-1628 (2001).
45. sanda, M. G. et al. Quality of life and satisfaction with outcome among prostatecancer survivors. N. Engl. J. Med. 358, 1250-1261 (2008).
46. Daly, M. p. Quality of life in sexually active men with symptomatic benign prostatic hyperplasia: effects of treatment. Clin. Drug Investig. 25, 219-230 (2005).
47. Dorey, G. et al. randomised controlled trial of pelvic floor muscle exercises and manometric biofeedback for erectile dysfunction. Br. J. Gen. Pract. 54, 819-825 (2004).
48. Dahn, J. r. et al. physical activity and sexual functioning after radiotherapy for prostate cancer: beneficial effects for patients undergoing external beam radiotherapy. Urology 65, 953-958 (2005).
49. parsons, J. K. & Kashefi, c. physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms. Eur. Urol. 53, 1228-1235 (2008).
50. Xu, H. et al. effects of st John's wort and cYp2c9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide. Br. J. Pharmacol. 153, 1579-1586 (2008).
51. Barnes, J. et al. st John's wort (Hypericum perforatum L): a review of its chemistry, pharmacology and clinical properties. J. Pharm. Pharmacol. 53, 583-600 (2001).
52. Du, G. et al. chinese herbal medicine pc-spes ii induces the apoptosis of androgen-independent prostate carcinoma cell line pc-3 [chinese]. Zhonghua Nan Ke Xue 13, 563-567 (2007).
53. small, e. J. et al. prospective trial of the herbal supplement pc-spes in patients with progressive prostate cancer. J. Clin. Oncol. 18, 3595-3603 (2000).
54. Guns, e. s. et al. Mass spectral analysis of pc-spes confirms the presence of diethylstilbestrol. Can. J. Urol. 9, 1684-1688 (2002).
55. Oh, W. K. et al. prospective, multicenter, randomized phase ii trial of the herbal supplement, pc-spes, and diethylstilbestrol in patients with androgen-independent prostate cancer. J. Clin. Oncol. 22, 3705-3712 (2004).
56. American cancer society. pc-spes, pc-HOpe, and pc-cAre [online 19 June 2007], www. cancer.org/docroot/etO/content/etO-5-3X- pc-spes.asp?sitearea=etO (2009).
57. Bayne, c. W. et al. Serenoa repens (permixon): a 5-alpha-reductase types i and ii inhibitor-new evidence in a coculture model of BpH. Prostate 40, 232-241 (1999).
58. Boyle, p. et al. Meta-analysis of clinical trials of permixon in the treatment of symptomatic benign prostatic hyperplasia. Urology 55, 533-539 (2000).
59. Wilt, t., ishani, A. & MacDonald, r. Serenoa repens for benign prostatic hyperplasia. Cochrane Database of Systematic Reviews 2002, issue 3. Art. No.: cD001423. doi:10.1002/14651858.cD001423.
60. Bent, s. et al. saw palmetto for benign prostatic hyperplasia. N. Engl. J. Med. 354, 557-566 (2006).
61. rao, A. v. et al. Lycopene. Adv. Food Nutr. Res. 51, 99-164 (2006).
62. Bertram, J. s. carotenoids and gene regulation. Nutr. Rev. 57, 182-191 (1999).
63. Dahan, K. et al. Lycopene in the prevention of prostate cancer. J. Soc. Integr. Oncol. 6, 29-36 (2008).
64. schwarz, s. et al. Lycopene inhibits disease progression in patients with benign prostate hyperplasia. J. Nutr. 138, 49-53 (2008).
65. Kucuk, O. et al. phase ii randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol. Biomarkers Prev. 10, 861-868 (2001).
66. Jatoi, A. et al. A tomato-based, lycopenecontaining intervention for androgenindependent prostate cancer: results of a phase ii study from the North central cancer treatment Group. Urology 69, 289-294 (2007).
67. Nagata, Y. et al. Dietary isoflavones may protect against prostate cancer in Japanese men. J. Nutr. 137, 1974-1979 (2007).
68. devere White, r. W. et al. effects of a genisteinrich extract on psA levels in men with a history of prostate cancer. Urology 63, 259-263 (2004).
69. combs, G. F. Jr et al. An analysis of cancer prevention by selenium. Biofactors 14, 153-159 (2001).
70. Diwadkar-Navsariwala, v. et al. selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model. Proc. Natl Acad. Sci. USA 103, 8179-8184 (2006).
71. Husbeck, B. et al. inhibition of androgen receptor signaling by selenite and methylseleninic acid in prostate cancer cells: two distinct mechanisms of action. Mol. Cancer Ther. 5, 2078-2085 (2006).
72. Klein, e. A. et al. seLect: the next prostate cancer prevention trial. selenium and vitamin e cancer prevention trial. J. Urol. 166, 1311-1315 (2001).
73. Yoshizawa, K. et al. study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J. Natl Cancer Inst. 90, 1219-1224 (1998).
74. Hartman, t. J. et al. The association between baseline vitamin e, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol. Biomarkers Prev. 7, 335-340 (1998).
75. Lippman, s. M. et al. effect of selenium and vitamin e on risk of prostate cancer and other cancers: the selenium and vitamin e cancer prevention trial (seLect). JAMA 301, 39-51 (2009).
76. ishani, A. et al. Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis. Am. J. Med. 109, 654-664 (2000).
77. Jepson, r. G. & craig, J. c. A systematic review of the evidence for cranberries and blueberries in Uti prevention. Mol. Nutr. Food Res. 51, 738-745 (2007).
78. Lawenda, B. D. et al. should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J. Natl Cancer Inst. 100, 773-783 (2008).